Skip to main content

Day: October 4, 2021

Cornish Metals Provides Update on TSX-V Approval for the Restructuring of the Deferred Consideration Payable for the Cornwall Assets

VANCOUVER, British Columbia, Oct. 04, 2021 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V/AIM: CUSN) (“Cornish Metals” or the “Company”) reports that, further to its news release dated June 30, 2021, the Company wishes to provide an update on its agreement (the “Side Letter”) with Galena Special Situations Limited (formerly Galena Special Situations Master Fund Limited) (“Galena”) and Tin Shield Production Inc. (“Tin Shield” and together with Galena, the “Sellers”) to restructure the deferred consideration (the “Deferred Consideration”) to be paid to the Sellers on the acquisition of the South Crofty tin project and associated mineral rights in 2016 (for further details, please see news releases dated March 17, 2016 and June 30, 2021). The Company received conditional approval from the TSX-V in respect of the Side Letter on August...

Continue reading

NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy

UPPSALA, SWEDEN – LIDDS AB (publ) announced today that no further patients will be enrolled in its dose escalating Phase I study (NZ-DTX-001) with the primary objective to study safety of NanoZolid®-docetaxel in solid tumors. The data collected in the trial demonstrates safety and tolerability, an active and local drug release of docetaxel over an extended period of time and signs of clinical effect in injected tumors. LIDDS plan to communicate the topline results from the study in Q4 2021. “We have reached an important milestone with the final enrollment of patients in the NZ-DTX-001 study. Preliminary assessments and observations indicate good safety and tolerability in patients treated intratumorally with NanoZolid®-docetaxel. After proper closing of the study, we intend to communicate next step forward for the program” said Nina Herne,...

Continue reading

Flushing Financial Corporation to Host Third Quarter 2021 Earnings Call

UNIONDALE, N.Y., Oct. 04, 2021 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq-GS: FFIC), the parent holding company for Flushing Bank (the “Bank”), today announced that it will release its third quarter 2021 earnings after the market closes on Tuesday, October 26, 2021. John R. Buran, President and Chief Executive Officer, and Susan K. Cullen, Senior Executive Vice President and Chief Financial Officer, will host the conference call on Wednesday, October 27, 2021 at 9:30 AM (ET) to discuss the Company’s strategy and results for the third quarter of 2021. Interested parties are invited to listen in by dialing 1-877-509-5836. The conference call will be simultaneously webcast at https://services.choruscall.com/links/ffic211027.html and archived through October 27, 2022. Conference Call Details Dial-in for...

Continue reading

Valneva Announces the Cancellation of Ordinary Shares Held by the Company following Termination of its Liquidity Agreement

 Saint-Herblain (France), October 4, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Management Board has decided, during a meeting today, to cancel all ordinary shares held by the Company following the termination of its liquidity agreement with Oddo BHF on June 11, 2021 (i.e., 4,025 ordinary shares in total, representing 0.004% of the share capital). The Company’s share capital is now set at 14,986,674.45 Euros, divided into 99,890,649 ordinary shares and 20,514 preferred shares convertible into ordinary shares, with a par value of 0.15 Euro each (i.e. 99,911,163 Shares in total). About Valneva SEValneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company...

Continue reading

Pres RELEASE: PILLAR III RISK REPORTS AS OF DECEMBER 31, 2020 AND JUNE 30, 2021 (AMENDED VERSION DATED 2021-10-04)

     Monday, October 4, 2021 PILLAR III RISK REPORTS AS OF DECEMBER 31, 2020 AND JUNE 30, 2021 (AMENDED VERSION DATED 2021-10–04) Amended versions of the Pillar III reports as of 12/31/2020 and 06/30/2021 are available on our website rcibs.com under the references “PILLAR 3 DISCLOSURES 2020-12-31 (AMENDED VERSION DATED 2021-10-04)” and “PILLAR 3 DISCLOSURES 2021-06-30 (AMENDED VERSION DATED 2021-10-04)”. Changes versus initial releases are linked to error corrections on tables EU LIQ1 related to quantitative information of LCR (for the reports as of 12/31/2020 and 06/30/2021) and “EU KM1 – Key metrics template” (for the report as of 06/30/2021). Indeed, two lines related to total net cash outflows and liquidity coverage ratio (LCR) are modified, as well as the comment of table EU LIQ1 for the report as of 06/30/2021. This new...

Continue reading

Pacific Urban Residential Announces Merger with Affiliate Hanover Real Estate Investors

PALO ALTO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) — Multifamily owner-operator and investment manager Pacific Urban Residential (”Pacific”) and multifamily private equity investor Hanover Real Estate Investors (“Hanover”) announced a merger between the two firms. The combined company is to be named Pacific Urban Investors, LLC and will be headquartered in Palo Alto, CA with six regional offices located in Los Angeles, Irvine, Seattle, Denver, New York, and Washington DC. Pacific is one of the most active multifamily investors in the US. The firm has proven adept at identifying and deploying multifamily strategies, including pioneering institutional investment into the vintage multifamily space. Founded in 1998 PUR is exclusively focused on multifamily strategies, investing significant PUR partner capital alongside institutional...

Continue reading

Kering – Disclosure of Transactions in Own Shares – September 27 to October 1st, 2021

Paris, October 4, 2021,     Disclosure of Transactions in Own Shares   In accordance with the authorization given by the shareholders’ annual meeting on July 6, 2021 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from September 27 to October 1st, 2021:Issuer’s name Issuer’s identifying code Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares Market (MIC code)KERING 549300VGEJKB7SVUZR78 27/09/2021 FR0000121485 19,500 626.7931 XPARKERING 549300VGEJKB7SVUZR78 28/09/2021 FR0000121485 19,500 612.7272 XPARKERING 549300VGEJKB7SVUZR78 29/09/2021 FR0000121485 19,500 620.7638 XPARKERING 549300VGEJKB7SVUZR78 30/09/2021...

Continue reading

Clever Leaves to Present at Upcoming October Investor Events

NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor events in October 2021: A.G.P. Virtual Fall Consumer Cannabis ConferenceAttending: Tuesday, October 5thWhere: Virtual 1×1 meeting format (no presentations) Lytham Partners Fall 2021 Investor ConferencePanel: Thursday, October 7th at 11:00 a.m. ET Webcast: https://bit.ly/3urbbpe MJBizCon Panel: Thursday, October 14th at 12:00 p.m. ETIn-Person Attendance: Wednesday, October 20th to Friday, October 22ndWhere: Las Vegas Convention Center, Las Vegas, NVAgenda and Registration: https://bit.ly/3onbzUI Benzinga Cannabis Capital ConferencePresentation: Friday, October...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.